Pharma Facing Government Pressure To Boost Profits, Security May Suffer
Some in the pharma industry have begun to outsource the testing phase of drug research to 3rd party companies.
With an approaching U.S. presidential election in which health care will be a major issue, the drug makers are clearly in the political cross-hairs.
What this may mean for security, in the short term, are budget cuts. Cutting security shows up in the bottom line immediately – but eventually ends up costing more in the long term.
